tiprankstipranks
Willow Biosciences Strikes Key Deal with Kalsec Inc.
Company Announcements

Willow Biosciences Strikes Key Deal with Kalsec Inc.

Story Highlights

Willow Biosciences Inc (TSE:WLLW) has released an update.

Don't Miss our Black Friday Offers:

Willow Biosciences Inc. has signed a significant commercial license and royalty agreement with Kalsec Inc., set to enhance Willow’s financial position with milestone and royalty payments upon the commercialization of a new natural ingredient for savory foods. The partnership is expected to bolster Kalsec’s market share in a $200M segment, with R&D concluding in 2024 and further regulatory and scaling efforts extending into 2025. This collaboration highlights Willow’s commitment to delivering sustainable and safe natural products through its advanced biotech platforms.

For further insights into TSE:WLLW stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskWillow Biosciences Launches $2M Private Placement
TipRanks Canadian Auto-Generated NewsdeskWillow Biosciences Sees Record Q3 Revenue Growth
TipRanks Canadian Auto-Generated NewsdeskWillow Biosciences Partners for Ingredient Development
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App